Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

13.08
Delayed Data
As of 4:00pm ET
 -0.76 / -5.49%
Today’s Change
10.85
Today|||52-Week Range
38.89
-63.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues6.5B5.8B6.0B5.8B
 
 
 
 
 
Cost of Goods Sold2.8B2.4B2.4B2.5B
 
 
 
 
 
Depreciation And Amortization331.7M495.2M607.5M587.2M
 
 
 
 
 
 
Operating ExpensesGross Income3.4B2.9B3.0B2.7B
 
 
 
 
 
General Expenses2.1B1.7B1.8B1.8B
 
 
 
 
 
Research And Development683.4M471.4M511.7M562.5M
 
 
 
 
 
Total Operating Expenses5.2B4.6B4.8B4.9B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.3B1.2B1.2B937.1M
 
 
 
 
 
Extraordinary Credit----4.2M24.8M
 
 
 
Extraordinary Charge-1.5B-260.0M-7.2B-560.4M
 
 
 
 
 
Interest Expense On Debt480.6M135.1M241.1M267.3M
 
 
 
 
 
Equity In Earnings-3.0M7.2M-14.7M-3.1M
 
 
 
 
 
Other Expenses-221.8M-86.7M-5.3M-11.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-913.2M709.7M-6.3B122.8M
 
 
 
 
 
Income Taxes-57.0M-55.7M-23.2M-509.8M
 
 
 
 
 
Minority Interest-999.2K-4.1M---15.5M
 
 
 
 
Preferred Dividend-64.9M-67.1M-68.4M-67.1M
 
 
 
 
 
Net Income-972.2M665.4M-6.3B614.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.0B1.0B1.0B1.0B
 
 
 
 
 
Shares To Calculate EPS Diluted1.0B1.0B1.0B1.0B
 
 
 
 
 
 
Earnings Per ShareEPS-$1.11$0.59-$6.25$0.54
 
 
 
 
 
EPS Diluted-$1.02$0.59-$6.24$0.54